Holocene Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-257,526
Closed -$13.1M 931
2024
Q4
$13.1M Buy
257,526
+241,745
+1,532% +$11.9M 0.04% 281
2024
Q3
$651K Sell
15,781
-34,142
-68% -$1.64M ﹤0.01% 644
2024
Q2
$2.4M Buy
+49,923
New +$2.21M 0.01% 469
2024
Q1
Sell
-19,219
Closed -$1.25M 897
2023
Q4
$1.25M Buy
+19,219
New +$1.16M ﹤0.01% 589
2023
Q2
Sell
-35,504
Closed -$2.19M 886
2023
Q1
$2.19M Buy
35,504
+22,806
+180% +$1.37M 0.01% 446
2022
Q4
$807K Buy
+12,698
New +$921K ﹤0.01% 581
2021
Q4
Sell
-19,421
Closed -$1.57M 1002
2021
Q3
$1.57M Sell
19,421
-10,497
-35% -$882K 0.01% 598
2021
Q2
$2.79M Buy
+29,918
New +$2.9M 0.02% 483
2020
Q4
Sell
-3,612
Closed -$249K 874
2020
Q3
$249K Buy
+3,612
New +$232K ﹤0.01% 630

Other funds holding NARI

Holocene Advisors's NARI Position: Q1 2025 in Review

Holocene Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 257,526 shares — an estimated $13.1M sold.

Holocene Advisors first reported a position in NARI in Q3 2020 and held it in 9 quarters. The position peaked at $13.1M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Holocene Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Holocene Advisors sold 257,526 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $13.1M.
  • Holocene Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Holocene Advisors's Inari Medical, Inc. Common Stock position peaked at $13.1M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Holocene Advisors's 13F filing for Q1 2025, filed 15 May 2025.